tazarotene

Acne in Patients with Skin of Color: Medical & Procedural Treatment Strategies
acneThe 2023 Skin of Color Update in New York City featured a comprehensive discussion on the evolving landscape of treating acne, with a particular focus on medical and procedural approaches. Attendees had the unique opportunity to hear Dr. Valerie Callendar, professor of dermatology at Howard University College of Medicine in Washington, DC,  and Dr. Andrew Alexis, Professor of Clinical Dermatology …
acne
Managing Psoriasis in Patients With Skin of Color: Get Expert Insights
psoriasisThe burden of psoriasis in patients with skin of color is significant, with reduced quality of life and often delayed diagnosis compared to patients with white skin. Andrew Alexis, MD, MPH, shares how he thinks learners will benefit from participating in this enduring educational activity from our symposium at the 2022 Skin of Color Update annual meeting in New York. [/vc_column_text][/vc_colum …
psoriasis
Skincare Mondays | Regrounding on Retinoids
retinoidsRetinoids Retinoids are a class of molecules derived from vitamin A or having structural and/or functional similarities to vitamin A.1 The first medicinal use of vitamin A dates back to ancient Egypt where liver juices were used to treat endemic night blindness.2 Prescribed topical retinoids are divided into 6 classes: Tretinoin (all-trans retinoic acid), adapalene, tazarotene, trifarotene, al …
retinoids
What’s New in Pediatric Acne? Stop Picking and Start Applying Well-Tolerated Retinoids!
PEDIATRIC ACNELinda Stein Gold, Director of Dermatology Clinical Research at Henry Ford Health System, lead us through “Acne across the ages” at the 17th Annual Women’s and Pediatric Dermatology Seminar. She busted through several acne myths, which are easily debunked with new acne medications: Clascoterone 1% cream: it reduces sebum production in the skin! Similar to spironolactone, it is an anti-andr …
PEDIATRIC ACNE
JDD Issue Highlights | June 2022: Acne & Rosacea
acneThe June 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on acne and rosacea, with original articles discussing topics such as improving rosacea outcomes in skin of color patients, pediatric and female acne, topical management of facial and truncal acne, and many more. Included in this issue are also case reports on bullous dermatitis and low dose Naltrexone in combination with PRP …
acne